These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7126418)

  • 1. Diuretic induced hypokalaemia: relationship to dosage interval and plasma aldosterone.
    McInnes GT; Shelton JR; Harrison IR; Perkins RM; Rigby GV
    Br J Clin Pharmacol; 1982 Sep; 14(3):449-52. PubMed ID: 7126418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone in thiazide-induced hypokalaemia: variable response between patients.
    Ramsay LE; Hettiarachchi J
    Br J Clin Pharmacol; 1981 Feb; 11(2):153-8. PubMed ID: 7213519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose liquorice alone or in combination with hydrochlorothiazide on the plasma potassium in healthy volunteers.
    Hukkanen J; Ukkola O; Savolainen MJ
    Blood Press; 2009; 18(4):192-5. PubMed ID: 19562574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diuretic therapy on adrenaline-induced hypokalaemia and hypomagnesaemia.
    Whyte KF; Whitesmith R; Reid JL
    Eur J Clin Pharmacol; 1988; 34(4):333-7. PubMed ID: 3402518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia.
    McInnes GT; Harrison IR; Shelton JR; Perkins RM; Clarke JM
    Br J Clin Pharmacol; 1984 Aug; 18(2):169-74. PubMed ID: 6487456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
    Murdoch DL; Forrest G; Davies DL; McInnes GT
    Br J Clin Pharmacol; 1993 Apr; 35(4):373-8. PubMed ID: 8485017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.
    McInnes GT; Shelton JR; Perkins RM; Harrison IR; Clarke JM
    Br J Clin Pharmacol; 1983 May; 15(5):564-6. PubMed ID: 6860532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, berne (CHDM).
    Widmer P; Maibach R; Künzi UP; Capaul R; Mueller U; Galeazzi R; Hoigné R
    Eur J Clin Pharmacol; 1995; 49(1-2):31-6. PubMed ID: 8751018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia.
    Kaplan NM; Carnegie A; Raskin P; Heller JA; Simmons M
    N Engl J Med; 1985 Mar; 312(12):746-9. PubMed ID: 3883170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretics and hypokalaemia: aldosterone antagonists or potassium supplementation?
    Demanet JC
    Acta Clin Belg; 1974; 29(3):176-8. PubMed ID: 4842207
    [No Abstract]   [Full Text] [Related]  

  • 11. The diurnal rhythm of plasma potassium: relationship to diuretic therapy.
    Solomon R; Weinberg MS; Dubey A
    J Cardiovasc Pharmacol; 1991 May; 17(5):854-9. PubMed ID: 1714003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic induced hypokalemia in the elderly.
    Navarro RP; O'Brien DK; Nuffort P; Spencer DL
    J Fam Pract; 1982 Apr; 14(4):685-9. PubMed ID: 7069387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis.
    Griffing GT; Melby JC
    Metabolism; 1989 Apr; 38(4):353-6. PubMed ID: 2725277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium and potassium. Inter-relationships in cardiac disorders.
    Wills MR
    Drugs; 1986; 31 Suppl 4():121-31. PubMed ID: 3732091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G; Beauchemin M; Vinay P; Gougoux A
    Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperreninism without hyperaldosteronism in diuretic abuse: a report of a case with identification of mefruside and ethacrynic acid in urine (author's transl)].
    Fuchs C; Hunneman DH; Scheler F
    Dtsch Med Wochenschr; 1977 Sep; 102(37):1319-22. PubMed ID: 902598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term diuretic treatment on body-potassium in heart-disease.
    Davidson C; McLachlan MS; Burkinshaw L; Morgan DB
    Lancet; 1976 Nov; 2(7994):1044-7. PubMed ID: 62899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.
    Stewart DE; Ikram H; Espiner EA; Nicholls MG
    Br Heart J; 1985 Sep; 54(3):290-7. PubMed ID: 4041299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.